Avastin® approved for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, recurrent/metastatic cervical cancer, metastatic HER2 negative breast cancer, RCC, GBM, NSCLCa; advanced cancers. The gene discussed is ERBB2; the disease is peritoneum cancer.